2022
DOI: 10.1002/mus.27738
|View full text |Cite
|
Sign up to set email alerts
|

A clinical bulbar assessment scale (CBAS) for amyotrophic lateral sclerosis

Abstract: Introduction/Aims: Comprehensive and valid bulbar assessment scales for use within amyotrophic lateral sclerosis (ALS) clinics are critically needed. The aims of this study are to develop the Clinical Bulbar Assessment Scale (CBAS) and complete preliminary validation. Methods:The authors selected CBAS items from among the literature and expert opinion, and content validity ratio (CVR) was calculated. Following consent, the CBAS was administered to a pilot sample of English-speaking adults with El Escorial defi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 118 publications
0
1
0
Order By: Relevance
“…Thus, CNS-BFS has been recommended for use in evaluating bulbar dysfunction [ 11 ]. In addition, the CNS-BFS can be applied as an important verification tool in the development of other objective, quantitative evaluation tools, such as the clinical bulbar assessment scale (CBAS) [ 12 ] and the amyotrophic lateral sclerosis-Bulbar dysfunction index (ALS-BDI) [ 13 ]. Like in the CNS-BFSC, the CNS-BFS C also exhibited good sensitivity in our study.…”
Section: Discussionmentioning
confidence: 99%
“…Thus, CNS-BFS has been recommended for use in evaluating bulbar dysfunction [ 11 ]. In addition, the CNS-BFS can be applied as an important verification tool in the development of other objective, quantitative evaluation tools, such as the clinical bulbar assessment scale (CBAS) [ 12 ] and the amyotrophic lateral sclerosis-Bulbar dysfunction index (ALS-BDI) [ 13 ]. Like in the CNS-BFSC, the CNS-BFS C also exhibited good sensitivity in our study.…”
Section: Discussionmentioning
confidence: 99%